Here are statistics and facts about seven device companies dominating the spine space.
DePuy Synthes spine (Raynham, Mass.)
DePuy Synthes is a part of New Brunswick, N.J.-based Johnson & Johnson, which saw sales of $17.8 billion in the third quarter of 2016. J&J noted an increase of 4.2 percent in Q3 sales, compared to Q3 of 2015.
The DePuy Synthes spine division unveiled its Kick system, which it developed with Germany-based BrainLab. The system includes FluoroExpress Software, and is designed to offer real-time, intraoperative visualization of instruments and implants in relation to patient anatomy. Surgeons may leverage the navigation to accurately place pedicle screws.
The spine division also launched the ZERO-P NATURAL plate in October 2016. The plate supports bone growth and stability during spinal fusion procedures in the neck.
Globus Medical (Audubon, Pa.)
Globus Medical saw $0.29 earnings per share and revenue of $135.7 million in the third quarter of 2016. Globus reported a net margin of 21.19 percent as well as a return on equity of 15.43 percent.
The company is working on Excelsius, its investigational robotics system, expecting technology approval and launch in 2017. The system features non-patient bedside docking and an optical tracking system.
K2M (Leesburg, Va.)
K2M surpassed estimates with its third quarter earnings results, citing $0.19 earnings per share. The company earned $59.30 million during Q3 2016. The company's revenue for Q3 2016 saw a 7.8 percent increase on a year-over-year basis.
Spine published the results of K2M's MESA Rail Deformity Spinal System study in its July 15, 2016 issue. The study was titled, "A Uniquely Shaped Rod Improves Curve Correction in Surgical Treatment of Adolescent Idiopathic Scoliosis." The MESA Rail includes a beam design offering rigidity for sagittal balance restoration. The study found patients with the beam rod experienced better curve correction (66 percent) compared to patients with the circular rod (57 percent).
Medtronic (Dublin, Ireland)
The company recently reported its financial results for the second quarter of 2017, ended Oct. 28, 2016, with reported Q2 worldwide revenue of $7.3 billion and U.S. revenue of $4.15 billion. Medtronic's spine group Q2 revenue totaled $663 million.
In August 2016, Medtronic placed a $20 million investment in Caesarea, Israel-based Mazor Robotics, including a purchase order for 15 Mazor X systems.
In 2022, Medtronic is expected to lead the board with total medtech sales of $39.9 billion, according to Evaluate Group.
NuVasive (San Diego)
NuVasive reported its financial results for the third quarter, ending Sept. 30, 2016. The company's revenue hit $239.6 million in Q3 of 2016, reflecting a 19.5 percent increase from the same period the year prior. NuVasive Chairman and CEO Gregory T. Lucier said the quarter's revenue fell short of expectations due to capital and stocking orders in the Untied States that did not arrive as expected.
In January, 2016, NuVasive acquired skeletal deformity medical device company Ellipse Technologies, including the MAGEC and PRECICE technologies, for $380 million. In October 2016, The FDA cleared magnetic resonance imaging for certain conditions on patients treated with the company's MAGEC system.
NuVasive held a Spine Summit from Oct. 13 to Oct. 14 in California, focused on topics that impact spine surgeon leaders as well as hospital and healthcare executives.
Stryker (Kalamazoo, Mich.)
Stryker reported $1.39 earnings per share in the third quarter of 2016, exceeding analyst expectations. The company also saw $2.83 billion in revenue, a 23.96 percent return on net equity and a 15.24 percent net margin. Quarterly revenue was up 17.1 percent on a year-over-year basis.
The company acquired CareFusion's vertebral compression fracture portfolio, which is comprised of minimally invasive systems used in vertebroplasty and vertebral augmentation procedures.
In October, 2016, Stryker's spine division unveiled its LITe BIO Delivery System, which is a hand-held device used to facilitate bone graft material delivery to spinal surgery sites.
The spine division also reported results from a pre-clinical study for its 3D-printed Tritanium PL Interbody Cages. The study found the Tritanium PL cages demonstrated reductions in segmental motion. Additionally, the cages exhibited increases in construct stiffness on all three loading directions between the eight- and 16-week post-implant time points.
Zimmer Biomet (Warsaw, Ind.)
Zimmer Biomet reported net sales of $183 billion in the third quarter of 2016, a 4 percent increase over the same period last year, and net earnings jumped 612.5 percent to $158.8 million. The company's spine sales hit $183.6 million, a 24.3 percent increase over the same period last year. The company is struggling with supply chain integration since the $13.35 billion merger of Zimmer and Biomet in 2015, as some of the product portfolio and customers overlap.
The company released two-year trial results of its Aspen MIS Fusion System as an adjunct to anterior and lateral interbody fusion, in November 2016. The trial revealed the Aspen MIS system is a clinically effective alternative to pedicle screw fixation for posterior stabilization.
More articles on devices:
Clinical data in support of Attune Knee System mounts: 3 notes
Mighty Oak Medical receives 2nd FDA clearance for pedicle screw navigation: 3 notes
NuVasive highlights its Integrated Global Alignment for the Cervical Spine platform: 4 points